✦ LIBER ✦

Notch inhibition blocks multiple myeloma cell-induced osteoclast activation

✍ Scribed by Schwarzer, R; Kaiser, M; Acikgoez, O; Heider, U; Mathas, S; Preissner, R; Sezer, O; Doerken, B; Jundt, F

Book ID: 109886490
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 330 KB
Volume: 22
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2008.138

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bortezomib Inhibits Osteoclast Activity

Bortezomib Inhibits Osteoclast Activity in Patients with Multiple Myeloma

✍ Uy, Geoffrey L.; Trivedi, Rachna; Peles, Shachar; Fisher, Nicholas M.; Zhang, Qi 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 93 KB

Atiprimod blocks STAT3 phosphorylation a

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

✍ Amit-Vazina, M; Shishodia, S; Harris, D; Van, Q; Wang, M; Weber, D; Alexanian, R 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 292 KB

P38 MAPK inhibition enhancing ATO-induce

P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells

✍ Jianguo Wen; Haiyun Y. Cheng; Yongdong Feng; Lawrence Rice; Shangfeng Liu; Alber 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

Blocking Notch1 signaling by RNA interfe

Blocking Notch1 signaling by RNA interference can induce growth inhibition in HeLa cells

✍ H. YU; X. ZHAO; S. HUANG; L. JIAN; G. QIAN; S. GE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Cyclic AMP induces apoptosis in multiple

Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model

✍ Virginie Follin-Arbelet; Peter O Hofgaard; Harald Hauglin; Soheil Naderi; Anders 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 528 KB

Alkylating agents induce activation of N

Alkylating agents induce activation of NFκB in multiple myeloma cells

✍ Philipp Baumann; Sonja Mandl-Weber; Fuat Oduncu; Ralf Schmidmaier 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Multiple myeloma is still not curable and drug combination strategies are currently being evaluated in order to achieve high remission rates with tolerable toxicity. Bortezomib has been shown to exert inhibitory effects on NFB activity. NFB in turn is known to be activated by cytokines, growth facto